Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
US7378500B2 · kind B2 · utility
4Cited by
2References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 4, 2006 |
| Grant date | May 27, 2008 |
| Priority date | — |
| Expiry date | Apr 4, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method of promoting healing of a chronic dermal skin ulcer, such as a diabetic ulcer, on a subject. The method comprises the step of contacting the chronic dermal skin ulcer with an effective amount of an agonist of the non-proteolytically activated thrombin receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.